PubMed Health⌕ Search

Biomedical subjects

C Graham

Publications and source records attributed to C Graham.

At least 163 records · Page 9Linked to original sources

Fatalities on the liquid-protein diet: an analysis of possible causes.

Reports of deaths occurring in patients using variants of the liquid-protein diet (LPD) have raised some questions about the safety of this procedure for the management of obesity. Case reports involving 44 publicized deaths were reviewed. Possible causes of death including such factors as potassium and/or electrolyte deficiencies, inadequate or poor quality protein, imperfect patient selection or compliance, an associated medications or disease were examined. Data in eight patients are insufficient for analysis or show that the patients were not using a LPD. Of the remaining 36 patients 32 were inappropriately managed as judged by conservative standards. Four patients who may have been properly managed all had known preexisting cardiac disease. The analysis does not identify any single factor which is responsible for the deaths. It shows that the procedure was widely misused and suggests that this contributed in multiple ways to the fatalities. No properly managed patient died as a direct result of the LPD and the cardiac deaths could not be ascribed to the LPD. Since the LPD, when properly supervised, has demonstrated great promise in the management of obesity, it is suggested that caution be exercised in dismissing the LPD because of adverse publicity.

Adult↗

Epidural analgesia and cardiac output in severe pre-eclamptics.

Labour and delivery cardiac output was assessed by thermal dilution in ten severe pre-eclamptics who received lumbar epidural analgesia. Control cardiac output was 8.8 litres/min which remained statistically unchanged following administration of lumbar epidural analgesia. At birth and delivery of the placenta, there was a moderate increase in cardiac output which increased significantly (28%) by 15 min after delivery of the placenta. Subsequently over the next hour, cardiac output returned toward baseline levels. Mother and fetus were stable throughout and infant Apgar scores were good. These results emphasise that lumbar epidural analgesia has little effect on cardiac output in severe pre-eclamptics.

Adolescent↗

Conservation of human research teeth by controlling cavity depth.

In order for the dental profession to obtain reliable data as to whether new or experimental restorative materials and adjunct agents are more or less irritating to pulp tissues than dental products currently in use, pulp studies at the national and international level are being standardized to enhance corroboration. The purpose of this study was to reduce the number of human teeth required in any experimental pulp toxicity study by controlling the problem of cavity depth. Many valuable teeth are wasted by making cavity preparations that are either too shallow or too deep, with consequent pulp exposures. This needs to be corrected.

Dental Cavity Preparation↗

Genital herpesvirus hominis type 2 infection: an experimental model in cebus monkeys.

Genital infection with herpesvirus hominis type 2 was established in ten female cebus monkeys. Clinical and laboratory findings in the cebus mimic closely those observed in humans, thus providing an experimental model which may be used in the study of the possible role of genital herpetic infection in cervical cancer and in perinatal and chronic neurological diseases.

Animals↗

Diazepam and lorazepam for intravenous surgical premedication.

Diazepam, 10 and 20 mg, and 2 and 4 mg lorazepam were studied as intravenous surgical premedicants in 120 patients. Relief of anxiety, sedation, patient acceptance, lack of recall, and side effects were the variables evaluated. Both diazepam and lorazepam proved to be excellent surgical premedicants. The basic difference between the two drugs is temporal. Both medications produce similar relief of anxiety, sedation, patient acceptance, and lack of recall. The clinical effects of intravenous diazepam peaks in 2 to 3 minutes and diminishes thereafter. Intravenous lorazepam has a latent period of 8 to 15 minutes, with increasing effects at 15 to 30 minutes.

Adolescent↗